Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javid Moslehi

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|April 22, 2020
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agentsRobert F Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
Circulation|January 12, 2026
Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse ModelsDilip Thomas, Amit Manhas, Yu Liu, et al.
JACC. Basic to Translational Science|November 27, 2019
Comparative Transcriptomics of <i>Ex Vivo</i>, Patient-Derived Endothelial Cells Reveals Novel Pathways Associated With Type 2 Diabetes MellitusJoshua A Beckman, Sean P Doherty, Zachary B Feldman, et al.
Diabetes Care|October 12, 2018
Increased Reporting of Immune Checkpoint Inhibitor-Associated DiabetesJordan J Wright, Joe-Elie Salem, Douglas B Johnson, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular DiseaseArvind K Pandey, Eric K Singhi, Juan Pablo Arroyo, et al.
Blood|May 22, 2012
Treatment of erythropoietin deficiency in mice with systemically administered siRNAWilliam Querbes, Roman L Bogorad, Javid Moslehi, et al.
Biological Research for Nursing|October 18, 2022
A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer SurgeryYing Sheng, Janet S Carpenter, Brenda J Smith, et al.
Transplantation and Cellular Therapy|October 25, 2025
Who Is Eligible for Chimeric Antigen Receptor T Cell Therapy? Expert Perspectives on Overcoming Referral BarriersMazyar Shadman, Sairah Ahmed, Michael T Byrne, et al.
British Journal of Haematology|October 20, 2017
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myelomaMichael G Fradley, John D Groarke, Jacob Laubach, et al.
Cardiovascular Research|February 5, 2019
Cardiovascular toxicities associated with immune checkpoint inhibitorsJiun-Ruey Hu, Roberta Florido, Evan J Lipson, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|April 22, 2020
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agentsRobert F Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
Circulation|January 12, 2026
Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse ModelsDilip Thomas, Amit Manhas, Yu Liu, et al.
JACC. Basic to Translational Science|November 27, 2019
Comparative Transcriptomics of <i>Ex Vivo</i>, Patient-Derived Endothelial Cells Reveals Novel Pathways Associated With Type 2 Diabetes MellitusJoshua A Beckman, Sean P Doherty, Zachary B Feldman, et al.
Diabetes Care|October 12, 2018
Increased Reporting of Immune Checkpoint Inhibitor-Associated DiabetesJordan J Wright, Joe-Elie Salem, Douglas B Johnson, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2017
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular DiseaseArvind K Pandey, Eric K Singhi, Juan Pablo Arroyo, et al.
Blood|May 22, 2012
Treatment of erythropoietin deficiency in mice with systemically administered siRNAWilliam Querbes, Roman L Bogorad, Javid Moslehi, et al.
Biological Research for Nursing|October 18, 2022
A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer SurgeryYing Sheng, Janet S Carpenter, Brenda J Smith, et al.
Transplantation and Cellular Therapy|October 25, 2025
Who Is Eligible for Chimeric Antigen Receptor T Cell Therapy? Expert Perspectives on Overcoming Referral BarriersMazyar Shadman, Sairah Ahmed, Michael T Byrne, et al.
British Journal of Haematology|October 20, 2017
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myelomaMichael G Fradley, John D Groarke, Jacob Laubach, et al.
Cardiovascular Research|February 5, 2019
Cardiovascular toxicities associated with immune checkpoint inhibitorsJiun-Ruey Hu, Roberta Florido, Evan J Lipson, et al.
Pageof 15